UConn advances in Alzheimer’s and bone disease
UConn Associate Professor of Medicine Anne Delany has received a $2.2 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
UConn Associate Professor of Medicine Anne Delany has received a $2.2 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to...
Biorez reports four new patents relating to Biorez’s proprietary BioBrace™ Implant, which is a biocomposite soft tissue scaffold intended to reinforce soft tissue repair, and act as a...
By Bill Claffey, tax attorney and partner at the accounting firm Fiondella, Milone and LaSaracina LLP (FML) The Connecticut R&D tax credit allows corporations to...
By Carine Boustany, Ph.D., SVP, US Development Site Head and Global Head of Development Sciences, Boehringer Ingelheim At Boehringer Ingelheim, we innovate ground-breaking medicines to...
There’s a better way to do cancer diagnostics, says Precipio DiagnosticsCEO Ilan Danieli. He points a finger at existing methodologies that stress cost saving over accuracy. While...
ReNetX Bio’s NoGo Trap therapeutic has been given “fast track” status by the Food and Drug Administration. The firm’s mission statement is clear and precise:...
As a co-founder of Cybrexa, Per Hellsund rejoined old colleagues Kevin Didden, Cybrexa board chair, and Kevin Rakin, a director. They are seeking to leverage research developed...
When James Rosen became president and CEO of Artizan Biosciences, it was a clear signal that Artizan was onto something big. Artizan’s initial product uses...
UConn has hit an impressive new high in external research funding, with its faculty attracting more than $375 million in new awards in the past...
Boehringer Ingelheim reports the acquisition of Abexxa Biologics, a Texas biotech. “The acquisition of Abexxa bolsters our commitment to tumor-antigen discovery and new ways of...